• General
  • Industry
  • Government & Politics
  • Other Language
  • Press Release
  • Home
  • Submit News
  • Contact Us
  • About Us
Pakistan Newswire
Menu
  • General
  • Industry
  • Government & Politics
  • Other Language
  • Press Release
 › Press Release › Nyxoah and Acurable Enter into Distribution Agreement in Germany for the AcuPebble SA100 Home Sleep Test

Nyxoah and Acurable Enter into Distribution Agreement in Germany for the AcuPebble SA100 Home Sleep Test

Web Desk August 2, 2022     Comment Closed     Press Release

Nyxoah and Acurable Enter into Distribution Agreement in Germany for the AcuPebble SA100 Home Sleep Test

Mont-Saint-Guibert, Belgium – August 2, 2022, 8:00am CET / 2:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company has entered into a distribution agreement with Acurable SL, a venture-backed medical device company developing wearable technologies for home use, to provide the AcuPebble SA100 home sleep test to OSA patients in Germany.

The AcuPebble SA100 is a next-generation wearable home sleep test that uses acoustic signals to diagnose OSA. The patient attaches the reusable AcuPebble sensor to the base of the neck to record sounds generated by the respiratory and cardiac functions. These recorded signals are uploaded to a secure cloud platform through a smartphone application where patented algorithms extract OSA parameters providing an automated diagnostic report within minutes. AcuPebble has demonstrated high levels of sensitivity and specificity for both the apnea-hypopnea index (AHI) and the oxygen-desaturation index (ODI) compared with the gold-standard polygraphy test, and is clinically validated through a randomized study published in the BMJ Open. The system is CE marked and has FDA clearance.

“With AcuPebble and Genio, Nyxoah can now offer patients and clinicians the most cutting edge OSA home sleep diagnosis and treatment solutions,” commented Olivier Taelman, Nyxoah’s Chief Executive Officer. “The Acurable partnership aligns perfectly with our patient-first mission statement, as AcuPebble’s comfort, ease-of-use and accuracy will break down barriers to OSA diagnosis and allow for more patients to receive treatment for their condition. We look forward to launching AcuPebble in Germany in the fourth quarter of 2022.”

“We are delighted to enter into this highly-synergistic collaboration with an OSA technology leader like Nyxoah, whose mission is aligned with ours of providing access to treatment to as many OSA patients as possible,” commented Emilio Sanz-Pereiras, Acurable’s Co-Chief Executive Officer. “AcuPebble is designed to be significantly more patient- and practitioner-friendly than polygraphy and polysomnography tests, enabling not only ease of diagnosis, but also the ability for patients to routinely monitor their condition. By empowering patients to take greater control over their OSA, AcuPebble is an important new tool to improve the lives of those suffering from this debilitating condition.”

About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext Brussels in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company is currently conducting the DREAM IDE pivotal study for FDA and US commercialization approval.

For more information, please visit http://www.nyxoah.com/.

Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.

Contacts:
Nyxoah
Loic Moreau, Chief Financial Officer
corporate@nyxoah.com
+32 473 33 19 80

Jeremy Feffer, VP IR and Corporate Communications
jeremy.feffer@nyxoah.com
+1 917 749 1494

Attachment

  • ENGLISH_Acurable Distribution Agreement PR FINAL
Press Release
MENAPakistan

 Previous Post

Eventbrite Welcomes Sapna Nair as Managing Director and VP of Engineering in India

― August 2, 2022

Next Post 

‫اثراء کا ہجرہ: نبی کے نقش قدم پر اسلام کے آغاز کا جدید نقطہ نظر سے دوبارہ جائزہ

― August 2, 2022

Related Articles

Web Desk ― February 1, 2023 | Comment Closed

FOLK HERO™ expands globally with push into Europe and the Middle East

New York, NY, Feb. 01, 2023 (GLOBE NEWSWIRE) — FOLK HERO™, [INVNT GROUP]’s brand strategy firm, is expanding its global operations into Europe and the Middle East, growing its storytelling reach across the region. FOLK HERO is a modern brand studio, brand consulting agency, and leading expert in global brand storytelling. The firm has led […]

Web Desk ― February 1, 2023 | Comment Closed

SAUDI ARABIA WINS HOSTING RIGHTS OF THE AFC ASIAN CUP™ 2027

Web Desk ― February 1, 2023 | Comment Closed

HYCU® Introduces World’s First Data Protection Development Platform for SaaS

Web Desk ― February 1, 2023 | Comment Closed

Boyden Appoints Distinguished Talent Solutions Leader Chad Hesters President & CEO

Web Desk ― February 1, 2023 | Comment Closed

SMPO Releases CP01 Disposable Pod Kit With Multiple Flavors And Large Capacity

Web Desk ― January 31, 2023 | Comment Closed

‫ایس اینڈ پی ڈاؤ جونز سسٹین ایبلٹی انڈیکس (ڈی جے ایس آئی) 2022 رینکنگ میں ویدانتا ایلومینیم دوسرے نمبر پر ہے

Web Desk ― January 31, 2023 | Comment Closed

‫ٹی اے کیو اے مشرق وسطی، شمالی افریقہ، وسطی ایشیا اور مشرقی یورپ تک توسیع کے لئے المنصوری پیٹرولیم سروسز کے 100 فیصد حصول کے لین دین بند کردی

Web Desk ― January 31, 2023 | Comment Closed

Vedanta Aluminium ranks 2nd in S&P Dow Jones Sustainability Index (DJSI) 2022 rankings

Search

Follow Us

Recent Posts

  • There is no room for forced conversion or marriage in Islam: Abdul Shakoor January 31, 2023
  • UNEP reiterates support to ‘Living Indus Initiative’ in Pakistan January 31, 2023
  • Pakistan, Russia agree to boost cooperation in diverse sectors January 31, 2023
  • Death toll in Peshawar blast rises to 100 January 31, 2023
  • PM terms terrorism as foremost national security challenge January 31, 2023
  • KP observes one-day mourning as death toll of Peshawar terror attack soars to 93 January 31, 2023
  • Development of Balochistan Govt’s top priority: PM January 31, 2023
  • CJCSC, IMCTC Secretary-General discuss counter-terrorism cooperation January 31, 2023
  • Pakistan-China border crossing at Khunjerab Pass re-opened for transportation January 30, 2023
  • PM expresses grief over death of children in Kohat boat mishap January 30, 2023
  • PM appeals to people for blood donations for injured in Peshawar terrorist attack January 30, 2023
  • AJK President urges Kashmiri, Pakistani diaspora to highlight plight of Kashmiris January 30, 2023

Advertisement

Calendar

February 2023
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728  
« Jan    


The strategy of the team behind “Pakistan news Wire.Net” is clear and it is to publish only authentic news as that is what the true journalism demands from any media outlet, and the “Pakistan News Wire. Net”, discourages the practice of opting for illegal approaches in order to get the ratings by any means. The more media outlets opt [...]

Archives

Search

Pages

  • Home
  • Submit News
  • Contact Us
  • About Us

Social Links

Copyright © 2020 - Pakistan News Wire. All Rights Reserved.